• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4672506)   Today's Articles (164)
For: Angusti T, DI Stefano RF, Parente A, Bungaro M, Turco F, Samuelly A, Pisano C, Scagliotti GV, DI Maio M, Tucci M, Buttigliero C. Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study. Minerva Urol Nephrol 2022;74:703-713. [PMID: 35147388 DOI: 10.23736/s2724-6051.22.04701-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Number Cited by Other Article(s)
1
Maggi M, Gandaglia G, Rajwa P, Martini A, Marra G. The current evidence on prognostic factors in metastatic castration-resistant prostate cancer patients treated with Radium-223. Minerva Urol Nephrol 2022;74:791-793. [PMID: 36629807 DOI: 10.23736/s2724-6051.22.05183-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
2
Rajwa P, Maggi M, Puche-Sanz I, Rempega G, Shariat SF, Zattoni F. Comment on: "Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society". Minerva Urol Nephrol 2022;74:816-818. [PMID: 36629815 DOI: 10.23736/s2724-6051.22.05182-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA